US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - World-news https://ift.tt/3bIUCMT
Saturday, November 6, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment